Taipei, Friday, October 20, 2017 22:16 (GMT+8)
cloudy
Taipei
22°C
Taiwan PCB makers ramping up capacity - related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES [Monday 19 November 2012]
  • APEX Medical
  • Performance
    The company's stock price closed at NT$30.85 on the TSE on Thursday, October 19, 2017.
    The company has reported consolidated revenues of NT$167 million for September 2017, representing a 20.6% drop on month and 22.2% increase on year.
    For the second quarter of 2017, the company totaled NT$542 million in consolidated revenues, up 15.6% sequentially and up 3% on year.
    Brief

    Full name: APEX Medical

    Chinese name: 雃博股份有限公司

    Short name: Apex

    Stock code: 4106

    Tax ID: 23632773

    Market: TSE

    Established: 17 Mar 1990

    Paid in capital: NT$833.86 million

    Listed on TSE: 8 Nov 2004

    Listed on OTC: 22 Jan 2002

    Listed on ESB: 2 Jan 2002

    Public since: 19 Jul 1999

    Website: cht.apexmedical.com.tw

  • Latest stock
    Apex [4106] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    20-Oct 76 57 2,324,261 30.90 30.90 30.40 30.70-0.15-0.49% 30.70 30.75
    19-Oct 80 62 2,461,100 30.75 30.95 30.60 30.85+0.10+0.33% 30.80 30.85
    18-Oct 86 66 2,651,620 31.00 31.00 30.70 30.75-0.25-0.81% 30.75 30.85
    17-Oct 93 74 2,880,100 31.10 31.10 30.80 31.00-0.15-0.48% 30.90 31.00
    16-Oct 96 65 2,992,550 31.15 31.30 31.10 31.15-0.15-0.48% 31.15 31.20
    13-Oct 76 53 2,374,050 31.25 31.45 31.15 31.30+0.05+0.16% 31.25 31.35
    12-Oct 255 155 7,964,869 31.40 31.80 30.90 31.25-0.65-2.04% 31.25 31.65
    11-Oct 172 109 5,493,998 32.05 32.20 31.70 31.90+0.20+0.63% 31.80 31.90
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Sep 2016 - Sep 2017 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Sep-17

    167

    (20.6%)

    22.2%

    1,577

    7.7%

    Aug-17

    211

    12.2%

    38%

    1,410

    6.2%

    Jul-17

    188

    6.4%

    34.3%

    1,199

    2.1%

    Jun-17

    176

    (11.9%)

    1%

    1,011

    (2.3%)

    May-17

    200

    20.9%

    16.4%

    835

    (2.9%)

    Apr-17

    166

    (17.5%)

    (7.7%)

    635

    (7.8%)

    Mar-17

    201

    46.7%

    13.5%

    469

    (7.8%)

    Feb-17

    137

    4.2%

    1.5%

    268

    (19.1%)

    Jan-17

    131

    (35%)

    (33.2%)

    131

    (33.2%)

    Dec-16

    202

    21.6%

    2.1%

    1,989

    (1.4%)

    Nov-16

    166

    6.6%

    2.8%

    1,787

    (1.8%)

    Oct-16

    156

    13.8%

    (8.4%)

    1,621

    (2.3%)

    Sep-16

    137

    (10.3%)

    (7%)

    1,465

    (1.5%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, October 2017

    Apex: Consolidated revenues, 2Q16 - 2Q17 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    2Q-17

    542

    15.6%

    3%

    1,011

    (2.3%)

    1Q-17

    469

    (10.8%)

    (7.8%)

    469

    (7.8%)

    4Q-16

    526

    22.4%

    (0.8%)

    1,990

    (1.3%)

    3Q-16

    430

    (18.4%)

    2.8%

    1,465

    (1.5%)

    2Q-16

    526

    3.5%

    (4.5%)

    1,035

    (3.1%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, October 2017

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 2Q16 - 2Q17 (NT$k)

    Item

    2Q-2017

    1Q-2017

    4Q-2016

    3Q-2016

    2Q-2016

    Current assets

    1,338,039

    1,233,710

    1,268,131

    1,108,550

    1,192,820

    Intangible assets

    420,386

    415,497

    432,513

    445,656

    467,711

    Non-current assets

    1,317,025

    1,273,566

    1,322,918

    1,318,301

    1,360,602

    Assets

    2,655,064

    2,507,276

    2,591,049

    2,426,851

    2,553,422

    Current liabilities

    804,349

    678,421

    738,224

    869,126

    967,005

    Non-current liabilities

    296,389

    295,241

    294,782

    5,427

    5,479

    Liabilities

    1,100,738

    973,662

    1,033,006

    874,553

    972,484

    Stockholders' equity

    1,554,326

    1,533,614

    1,558,043

    1,552,298

    1,580,938

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, October 2017

    Apex: Consolidated income statement, 2Q16 - 2Q17 (NT$k)

    Item

    2Q-2017

    1Q-2017

    4Q-2016

    3Q-2016

    2Q-2016

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

     

     

    469,035

     

    0

     

     

     

     

     

    Operating revenue

    542,086

    115.6%

    469,035

    100%

    525,757

     

    429,703

    79.3%

    526,243

    97.1%

    Gross profit (loss) from operations

    246,958

    52.7%

    211,420

    45.1%

    217,533

    41.4%

    192,185

    35.5%

    240,584

    44.4%

    Operating expenses

    182,293

    38.9%

    170,935

    36.4%

    188,896

    35.9%

    167,287

    30.9%

    190,327

    35.1%

    Operating income (loss)

    64,665

    13.8%

    40,485

    8.6%

    28,637

    5.4%

    24,898

    4.6%

    50,257

    9.3%

    Non-operating expenses and losses

    -3,328

    -0.7%

    -3,882

    -0.8%

    -8,381

    -1.6%

    3,988

    0.7%

    2,769

    0.5%

    Income from continuing operations before income tax

    61,337

    13.1%

    36,603

    7.8%

    20,256

    3.9%

    28,886

    5.3%

    53,026

    9.8%

    Net income (loss)

    48,498

    10.3%

    26,213

    5.6%

    15,624

    3%

    26,264

    4.8%

    33,766

    6.2%

    Diluted earnings per share (NT$)

    0.5

     

    0.3

     

    0.2

     

    0.3

     

    0.4

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, October 2017

  • APEX Medical full profile

20-Oct-2017 markets closed

 LastChange

TAIEX (TSE)10728.88-31.41-0.29% 

TSE electronic462.74-2.18-0.47% 

GTSM (OTC)144.77-0.10-0.07% 

OTC electronic217.69+0.04+0.02% 

Global notebook shipment forecast, 2017 and beyond
Global AP demand forecast, 2017-2020
Global notebook shipment forecast, 2017 and beyond
  • The 10nm competition

    TSMC and Samsung have been competing for clients for the 10nm node.

  • The SMIC ambition

    The China-based foundry has recently appointed Mong-song Liang as its co-CEO. Liang previously was a key player in advanced process R&D at TSMC and...

  • Morris Chang's legacy

    TSMC chairman has announced he will retire from TSMC in June 2018 after playing a leading role in Taiwan's semiconductor industry for three decades.

  • TSMC 3nm fab

    TSMC will build its 3nm fab in southern Taiwan.

  • China AMOLED panel capacity expansion forecast, 2016-2020

    This Digitimes Research Special Report examines the China AMOLED industry, focusing on the expansion capacity of the makers, the current implementation plans of major smartphone vendors in the market and the technological hurdles faced by the China makers.

  • Global AP demand forecast, 2017-2020

    Digitimes Research expects global AP shipments to surpass the 1.9 billion mark in 2017, with smartphones remaining the main application. Qualcomm will be leading the market in 2017, as other players continue playing catch up and scramble for funds to invest in more diverse applications.

  • Global notebook shipment forecast, 2017 and beyond

    This Digitimes Special Report examines key factors in the notebook industry, including products, vendors and ODMs, that will affect total shipments in 2017 and through 2021.